NCT02037776View on ClinicalTrials.gov

The Efficacy and Safety Study of Rikkunshito in Patients With Functional Dyspepsia

PHASE4CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

April 3, 2014

Primary Completion Date

March 25, 2016

Study Completion Date

March 25, 2016

Conditions
Functional Dyspepsia
Interventions
DRUG

Rikkunshito

\- Oral administration of rikkunshito (2.5 g t.i.d) before meals for 8 weeks

DRUG

Rikkunshito placebo

\- Oral administration of rikkunshito placebo (2.5 g t.i.d) before meals for 8 weeks

Trial Locations (1)

545-8585

Osaka City University Graduate School of Medicine, Abeno-ku

All Listed Sponsors
lead

Osaka City University

OTHER

NCT02037776 - The Efficacy and Safety Study of Rikkunshito in Patients With Functional Dyspepsia | Biotech Hunter | Biotech Hunter